SCHEDULE: Goldman Sachs Files Schedule 13G for Agilon Health

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting beneficial ownership of Agilon Health, Inc. common stock.

Summary

• The filing is an amendment to a Schedule 13G, indicating a change in beneficial ownership reporting for Agilon Health, Inc.
• The reporting persons are The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC.
• The filing states that Goldman Sachs & Co. LLC is a broker-dealer and investment adviser, a subsidiary of The Goldman Sachs Group, Inc.
• The aggregate amount of Agilon Health, Inc. common stock beneficially owned by each reporting person is 651,825.59 shares.
• This ownership represents 3.9% of the class of securities.
• The filing confirms that these securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral filing, primarily an administrative update regarding beneficial ownership, with no new financial or strategic information.

Positives

• Goldman Sachs & Co. LLC is a registered broker-dealer and investment adviser, indicating a regulated entity managing assets.
• The filing confirms that the securities are held in the ordinary course of business, suggesting standard investment practices.

Negatives

• The filing does not provide any new financial performance data or strategic updates for Agilon Health, Inc.

Risks

• The filing does not explicitly mention any risks related to Agilon Health, Inc. or the reporting entities.

Future Outlook

No forward-looking statements or guidance are provided in this filing.

Management Comments

• The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC certify that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are standard for institutional investors crossing certain ownership thresholds. This filing indicates Goldman Sachs's continued, albeit passive, investment in Agilon Health, Inc. within the healthcare services sector.

Stakeholder Impact

• Shareholders: The filing provides transparency on a significant institutional holder's stake, which can be relevant for market analysis.

Next Steps

• Continued reporting of beneficial ownership as required by SEC regulations.

Key Dates

Keywords

Schedule 13G, Beneficial Ownership, Agilon Health, Goldman Sachs, Securities Exchange Act, Broker-Dealer, Investment Adviser